Nonalcoholic Steatohepatitis (NASH) Clinical Trials
3 recruiting trials for Nonalcoholic Steatohepatitis (NASH). Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT03572465
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
Nonalcoholic fatty liver disease is the most common liver disease in Western countries, due in large part to its association with type 2 diabetes and obesity. The more advanced...
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 1021 location
RECRUITINGPhase 1NCT06947304
Evaluation of Miricorilant on Liver Fat in Patients With MASLD
A Phase 1, Open-Label Study Evaluating the Effect of Miricorilant on Hepatic Lipids in Patients with Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Sponsor: Corcept TherapeuticsEnrolling: 81 location
RECRUITINGPhase 1NCT06216041
To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects
This study will evaluate the safety, tolerability and pharmacokinetics (PK) of escalating single- and multiple-oral doses of IMM-H014 on fasted condition, and characterize PK of...
Sponsor: Changchun Intellicrown Pharmaceutical Co. LTDEnrolling: 1381 location